Further studies are needed to elucidate the mechanisms by which ABC transporter expression in the BBB decreases with aging, which could help to develop a novel medicine for age-related neurological disorders such as Alzheimer’s disease. This evidence concerns the gene ABCG2 and early-onset autosomal dominant Alzheimer disease.